Oryzon Genomics S.A. (ORY.MC)

EUR 2.66

(1.33%)

Operating Expenses Summary of Oryzon Genomics S.A.

  • Oryzon Genomics S.A.'s latest annual operating expenses in 2023 was 18.49 Million EUR , down -10.75% from previous year.
  • Oryzon Genomics S.A.'s latest quarterly operating expenses in 2024 Q3 was 2.79 Million EUR , down -9.9% from previous quarter.
  • Oryzon Genomics S.A. reported a annual operating expenses of 20.72 Million EUR in annual operating expenses 2022, up 22.8% from previous year.
  • Oryzon Genomics S.A. reported a annual operating expenses of 16.87 Million EUR in annual operating expenses 2021, up 27.04% from previous year.
  • Oryzon Genomics S.A. reported a quarterly operating expenses of 2.79 Million EUR for 2024 Q3, down -9.9% from previous quarter.
  • Oryzon Genomics S.A. reported a quarterly operating expenses of 3.24 Million USD for 2024 Q1, down -32.73% from previous quarter.

Annual Operating Expenses Chart of Oryzon Genomics S.A. (2023 - 2019)

Historical Annual Operating Expenses of Oryzon Genomics S.A. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 18.49 Million EUR -10.75%
2022 20.72 Million EUR 22.8%
2021 16.87 Million EUR 27.04%
2020 13.28 Million EUR 25.93%
2019 10.54 Million EUR 0.0%

Peer Operating Expenses Comparison of Oryzon Genomics S.A.

Name Operating Expenses Operating Expenses Difference
Atrys Health, S.A. 143.61 Million EUR 87.12%
Biotechnologies Assets SA 840.45 Thousand EUR -2100.858%
Pharma Mar, S.A. 152.36 Million EUR 87.86%
Laboratorios Farmaceuticos Rovi, S.A. 263.09 Million EUR 92.969%